36C26322Q0644_1.docx

DOCX document 16 KB Posted

Attached to
Q301--CareDx AlloSure Lab Test 07/01/2022 - 06/30/2023
Solicitation number
36C26322Q0644
Issued by

About this file

This document contains a justification and approval notice for a sole source contract award along with details of the related federal contract opportunity. The Sioux Falls, South Dakota VA Contracting Department plans to award a one-year, $568,150 sole source contract to CareDx, Inc. for molecular laboratory testing services including the AlloSure donor-derived cell-free DNA test. The services are required for the Iowa City VA Health Care System's Pathology and Laboratory Medicine Service and will aid in earlier identification of transplant rejection in kidney transplant patients compared to standard creatinine testing. Specifically, CareDx will provide AlloSure testing at months one, three, six, nine, and twelve post-transplant along with specimen collection kits, shipping supplies, reports, consultation, and a mobile lab service to draw samples from patients' homes at no additional cost. The period of performance is from July 1, 2022 to June 30, 2023.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Justification and Approval Notice Justification and Approval Notice

SUBJECT*
CareDx AlloSure Lab Test 07/01/2022 - 06/30/2023

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
57105
SOLICITATION NUMBER*
36C26322Q0644
DELIVERY/TASK ORDER NUMBER
36C26322C0092

BASE NOTICE TYPE

ARCHIVE
30 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N
PRODUCT SERVICE CODE*
Q301
NAICS CODE*
621511

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs

NETWORK 23 CONTRACTING OFFICE

2501 W. 22nd St.

Sioux Falls SD 57105

POINT OF CONTACT*

Scott Morrison scott.morrison2@va.gov

AWARD INFORMATION

STATUTORY AUTHORITY*
FAR2
AWARD NUMBER*
Y371A27ZEUM4

MODIFICATION NUMBER

AWARD AMOUNT*
568,150.00

LINE ITEM NUMBER

AWARD DATE (MM-DD-YYYY)*
08-10-2022

AWARDEE NAME*

CONTRACTOR’S UEI

CAREDX, INC.

Y371A27ZEUM4

AWARDEE ADDRESS LINE 1*

AWARDEE ADDRESS LINE 2*

AWARDEE ADDRESS LINE 3*
3260 BAYSHORE BLVD

AWARDEE ADDRESS LINE 4*

AWARDEE CITY
BRISBANE
AWARDEE STATE
CA
AWARDEE ZIP CODE
94005

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION
scott.morrison2@va.gov

DESCRIPTION

The Sioux Falls, SD VA Contracting Department anticipates award of the following sole source procurement due to an Unusual and Compelling Urgency per 41 USC §3304(a)(2) as implemented by FAR 6.302-2 exists.

A 12 month service contract shall be awarded on a sole source basis for molecular laboratory testing services for the Iowa City Health Care System (ICHCS), Pathology and Laboratory Medicine Service. The time period will be for one year.

1. This request is for molecular laboratory testing to include CareDx AlloSure Donor Derived Cell-Free DNA testing. The Iowa City VA is a major kidney transplant organ center for the VA, roughly performing one transplant a week for patients across the United States. The purpose of this test is to identify transplant rejection earlier compared to waiting on serum creatinine to start increasing which means there is more significant allograft damage to the patient. This AlloSure test by CareDx is the only non-invasive test that can assess organ health by directly measuring allograft injury. Testing for patients would occur at months 1, 3, 6, 9 and 12 post transplant.

Services will be available Monday through Friday 0800 – 1700 PST, excluding federal and contractor holidays. The contractor will provide specimen collection kits, requisitions, shipping supplies including prepaid shipping labels, specimen final result reports, direct data review, real time consultation and preliminary result reports when requested. The Contractor shall provide a mobile lab service for drawing patient samples at the patient’s home at no additional cost to the ICVAHCS or patient. If requested, additional laboratory specimens pertinent to patient care shall also be drawn and delivered to the ICVAHCS at no additional cost. The ICVAHCS shall communicate what additional samples to draw and provide the contractor with copies of laboratory orders in a timely manner prior to the mobile lab arriving at the patient’s home. AlloSure samples drawn at the patient’s home shall be mailed directly to Contractor by the mobile lab service technician.

The base period of performance will be from 07/01/2022 to 06/30/2023 with an estimated value of $568,150.00.

*= Required Field
Justification and Approval Notice

Justification and Approval Notice

File details come from the government source that posted it. Updated .